Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AEF0117 for Treatment-seeking Patients With Cannabis Use Disorder
NCT05322941Phase 2Completed
- Sponsor
- Aelis Farma
- Start
- May 2022
- Primary completion
- Apr 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of aef0117 in cannabis use disorder (CUD), sponsored by Aelis Farma. Started May 2022; status: completed.
02
Drugs
aef0117
03
Conditions
cannabis use disorder (CUD)
Beyond the preview
Go deeper on NCT05322941.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05322941.